SCHEMBL7952407

SCHEMBL7952407

N#CC(S)c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
ALDH1A1 P00352 3/20 0.46
ALPG P10696 2/20 0.46
HPGD P15428 2/20 0.41
USP2 O75604 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
IDO1 P14902 3/20 0.38
TDO2 P48775 2/20 0.38
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8018943 0.76 ALDH1A1 (0.42) LMNASMN1; SMN2ALDH1A1HTTTDP1
SCHEMBL9782123 0.76 IDO1 (0.38) LMNASMN1; SMN2ALDH1A1ALPGHPGD
SCHEMBL7964772 0.76 KIF11 (0.44) ALDH1A1KMT2AKDM4E
SCHEMBL30564952 0.76 KMT2A (0.42) LMNASMN1; SMN2ALDH1A1ALPGHPGD
SCHEMBL7252442 0.75 LMNA (0.48) LMNASMN1; SMN2ALDH1A1ALPGHPGD
SCHEMBL4592906 0.75 TSHR (0.52) LMNASMN1; SMN2ALDH1A1HPGDUSP2
SCHEMBL1508006 0.75 ALDH1A1 (0.70) LMNASMN1; SMN2ALDH1A1ALPGHPGD
SCHEMBL7958219 0.73 LMNA (0.47) LMNASMN1; SMN2ALDH1A1ALPGHPGD
SCHEMBL1193246 0.73 CHRNB2 (0.42) ALDH1A1TDP1
SCHEMBL6908022 0.71 TSHR (0.60) LMNASMN1; SMN2ALDH1A1ALPGHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed